Pharmafile Logo
Pharmafocus logo
Advanced Search
EMA image

EMA recommends eight drugs for approval

May 22, 2015
Sales and Marketing Amgen, BMS, EMA, Janssen, Merck, keytruda

The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha …

News
Bayer image

Bayer wins Cancer Drugs Fund appeal

May 22, 2015
Sales and Marketing Bayer, CDF, Cancer Drugs Fund, Eisai, NHS, lilly

Bayer is the only company to win its appeal to NHS England in the latest round of Cancer Drugs Fund …

News
Sanofi image

Sanofi’s rheumatoid arthritis biologic performs

May 22, 2015
Sales and Marketing Sanofi, rheumatoid arthritis, sarilumab

French pharma giant Sanofi plans to submit its new rheumatoid arthritis biologic for regulatory approval in the US after it …

News

Boehringer and Eureka reach cancer antibodies deal

May 22, 2015
Research and Development, Sales and Marketing Boehringer, eureka

Boehringer Ingelheim and Eureka Therapeutics have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology.No …

News
julian_gangolli

GW Pharma appoints president and moves CEO to US

May 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GW Pharmaceuticals, Julian Gangolli

US biopharma firm GW Pharmaceuticals has appointed Julian Gangolli as president of its North American division, and is also relocating its …

Appointment

Analysts predict Pfizer to swallow GSK

May 21, 2015
Sales and Marketing AZ, GSK, GlaxoSmithKline, Pfizer, merger

GlaxoSmithKline has been suggested as a potential M&A target for Pfizer, despite the US company backing out of a similar …

News

Pharma firm seeks judicial review against transparency

May 21, 2015
Medical Communications, Research and Development, Sales and Marketing Richmond Pharmacology, hra, transparency

The battle for greater transparency in the pharma industry is to take another twist after a company lodged a legal …

News
J&J image

J&J to file 10 new key drugs by 2019

May 21, 2015
Sales and Marketing J&J, JJ

Johnson & Johnson says it plans to file 10 new products with regulators between 2015 and 2019 with each having …

News
marc_tessier-lavigne

Pfizer board member stepping down

May 21, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Marc Tessier-Lavigne, Pfizer

Dr Marc Tessier-Lavigne is leaving Pfizer’s board of directors to work on the launch of Denali, a new biotech company …

Appointment

Industry awaits key immunotherapy results at ASCO

May 20, 2015
Research and Development, Sales and Marketing ASCO, Cancer, oncology, pharma

This year’s American Society of Clinical Oncology (ASCO) conference has a strong focus on immunotherapy, as pharma ramps up its …

News

Scottish government doubles fund for new medicines

May 20, 2015
Research and Development, Sales and Marketing Scotland, cystic fibrosis, medicines

The Scottish government will increase its New Medicines Fund next year to double the amount of money available to fund …

News

NHS online starting to take shape

May 20, 2015
Medical Communications, Sales and Marketing HSCIC, NHS, brett wells, nhs online

In England over 55 million patients can now order repeat prescriptions, book GP appointments and access their medical records online …

News
jonathan_p

Amgen hires senior VP, general counsel and secretary

May 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, jonathan graham

Amgen has appointed Jonathan Graham as its senior vice president, general counsel and secretary who will take to his post in July. …

Appointment

Merck KGaA’s sales climb but key drugs fall

May 19, 2015
Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif

Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

News
endo image

Endo lands a big fish with $8 billion Par Pharma deal

May 19, 2015
Sales and Marketing Endo, Valeant, par pharma

Endo is switching strategies from attempting to buy specialist pharma firms, to generics, having announced a huge $8 billion deal …

News
Astrazeneca image

AstraZeneca building $285m biologics plant in Sweden

May 19, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, Sweden, Södertälje, brett wells

AstraZeneca is spending around $285 million on a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The …

News
zahind_ali

Pfizer head joins UK biotech Calchan

May 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, calhan, zahid ali

UK-based biotech Calchan has looked to Pfizer for appointing a new chief scientific officer in Zahid Ali. Ali has almost …

Appointment
NHS image

Cameron restates £8 billion NHS funding plans

May 18, 2015
Sales and Marketing BMA, Cameron, NHS, UK

UK prime minister David Cameron has committed to extra funding for the NHS in his first major speech following the …

News
FDA image

FDA issues more diabetes drug warnings

May 18, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Boehringer, J&J, JJ, lilly

The FDA has warned that a class of type 2 diabetes drugs manufactured by several big pharma firms could cause …

News

Boehringer widens IPF drug’s reach

May 18, 2015
Sales and Marketing Boehringer, Esbriet, ats, brett wells, nintedanib, ofev

Boehringer Ingelheim has highlighted new data for its idiopathic pulmonary fibrosis (IPF) treatment Ofev in a Phase II study on …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026